No takes yet. Share an insight, caveat, or question.
Research reveals CAR T cell immunotherapy enhances T cell responses in melanoma and lung cancer, suggesting improved outcomes for checkpoint blockade therapy.
Kalia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: